• Thumbnail for Gilead Sciences
    Gilead Sciences, Inc. (/ˈɡɪliəd/) is an American biopharmaceutical company headquartered in Foster City, California that focuses on researching and developing...
    77 KB (7,528 words) - 09:05, 14 April 2024
  • Thumbnail for Remdesivir
    Remdesivir (category Gilead Sciences)
    broad-spectrum antiviral medication developed by the biopharmaceutical company Gilead Sciences. It is administered via injection into a vein. During the COVID‑19...
    113 KB (9,806 words) - 22:53, 14 February 2024
  • Annual Report 2017" (PDF). "Gilead Sciences Announces Fourth Quarter and Full Year 2023 Financial Results". "Gilead Sciences Announces Fourth Quarter and...
    61 KB (2,701 words) - 11:52, 23 April 2024
  • a 2004 novel by Marilynne Robinson Gilead, a novelette by Zenna Henderson in her Ingathering series Gilead Sciences, an American biopharmaceutical company...
    2 KB (257 words) - 20:04, 24 June 2022
  • Kite Pharma (category Gilead Sciences)
    2017, Gilead Sciences announced that it would acquire Kite Pharma for $11.9 billion in an all-cash deal, a 29% premium on the share price. Gilead made...
    45 KB (4,136 words) - 07:33, 29 February 2024
  • Thumbnail for Cidofovir
    Cidofovir (category Gilead Sciences)
    Prague, by Antonín Holý, and developed by Gilead Sciences and is marketed with the brand name Vistide by Gilead in the US, and by Pfizer elsewhere. Cidofovir...
    15 KB (1,352 words) - 23:05, 17 April 2024
  • Thumbnail for Emtricitabine/tenofovir
    Emtricitabine/tenofovir (category Gilead Sciences)
    combination is owned by Gilead Sciences in some regions. The European patent EP0915894B1 expired in July 2018, Gilead Sciences wished the patent to be...
    28 KB (2,304 words) - 23:29, 30 March 2024
  • Thumbnail for GS-441524
    GS-441524 is a nucleoside analogue antiviral drug which was developed by Gilead Sciences. It is the main plasma metabolite of the antiviral prodrug remdesivir...
    22 KB (2,197 words) - 18:41, 30 April 2024
  • Thumbnail for John C. Martin (businessman)
    John C. Martin (businessman) (category Gilead Sciences people)
    biotechnology company Gilead Sciences. He joined Gilead Sciences in 1990 as vice president for research and development. Gilead is known for developing...
    15 KB (1,443 words) - 20:01, 7 April 2024
  • varicella zoster virus guanosine analogue RTI 1981 Adefovir Hepatitis B Gilead Sciences RTI 2002 (FDA), 2003 (EU) Amantadine Influenza Influenza A virus M2...
    13 KB (513 words) - 14:31, 4 May 2024
  • Thumbnail for Zydus Lifesciences
    Indian pharma companies that received the licensing agreements from the Gilead Sciences to produce remdesivir. Zydus Cadila's major shareholder remains the...
    14 KB (1,168 words) - 22:15, 21 April 2024
  • Thumbnail for Ranolazine
    Extended-Release Tablets, for Oral Use. Full Prescribing Information". Gilead Sciences, Inc. Foster City, CA 94404. Retrieved 8 September 2016. Rosa GM, Dorighi...
    17 KB (1,481 words) - 02:54, 31 March 2024
  • Thumbnail for Donald Rumsfeld
    Donald Rumsfeld (category Gilead Sciences people)
    named CEO of General Instrument from 1990 to 1993 and chairman of Gilead Sciences from 1997 to 2001. Rumsfeld was appointed Secretary of Defense for...
    178 KB (16,404 words) - 02:56, 19 April 2024
  • Thumbnail for Tenofovir disoproxil
    Tenofovir disoproxil (category Gilead Sciences)
    company Gilead Sciences led to the investigation of PMPA's potential as a treatment for HIV infected patients. In 1997 researchers from Gilead and the...
    26 KB (2,368 words) - 02:04, 31 March 2024
  • Thumbnail for Tenofovir alafenamide
    Tenofovir alafenamide (category Gilead Sciences)
    transcriptase inhibitor and is a prodrug of tenofovir. It was developed by Gilead Sciences based on the protide technology of Chris McGuigan and is applied in...
    29 KB (1,820 words) - 23:04, 17 April 2024
  • John F. Milligan is an American former executive who was the CEO of Gilead Sciences, a biotechnology company based in the United States from March 2016...
    4 KB (417 words) - 13:03, 12 November 2023
  • Thumbnail for Sofosbuvir
    Sofosbuvir (category Gilead Sciences)
    was first tested in people in 2010. In 2011, Gilead Sciences bought Pharmasset for about $11 billion. Gilead submitted the New Drug Application for sofosbuvir...
    64 KB (5,827 words) - 23:31, 6 February 2024
  • Thumbnail for Foster City, California
    There are many notable companies headquartered in Foster City like Gilead Sciences, Zoox, Sledgehammer Games, and Replit. Visa used to be headquartered...
    35 KB (3,030 words) - 04:53, 30 April 2024
  • Thumbnail for Bictegravir
    compound dolutegravir by scientists at Gilead Sciences. In vitro and clinical results were presented by Gilead in the summer of 2016. In 2016, bictegravir...
    13 KB (839 words) - 04:02, 28 February 2024
  • Thumbnail for Pre-exposure prophylaxis for HIV prevention
    "Pre-Exposure Prophylaxis (PrEP) for HIV Prevention" (PDF). Gilead Sciences Policy Position. Gilead Sciences. Retrieved 15 December 2017. "HIV prevention drug Truvada...
    74 KB (7,842 words) - 13:49, 9 May 2024
  • Thumbnail for Emtricitabine
    Emtricitabine (category Gilead Sciences)
    by Emory in 1996. Triangle Pharmaceuticals was acquired in 2003 by Gilead Sciences, which completed development and now markets the product with the brand...
    12 KB (919 words) - 10:21, 24 August 2023
  • Thumbnail for George Shultz
    George Shultz (category Fellows of the American Academy of Arts and Sciences)
    Shultz Resigns from Gilead Sciences Board of Directors Archived February 8, 2021, at the Wayback Machine (press release), Gilead Sciences, Inc. (December...
    90 KB (7,928 words) - 14:34, 1 May 2024
  • Men who have sex with men (category Sexual orientation and science)
    Retrieved January 12, 2017. Gilead Sciences Policy Position. "Pre-Exposure Prophylaxis (PrEP) for HIV Prevention" (PDF). Gilead Sciences. Retrieved December 15...
    37 KB (3,907 words) - 02:30, 18 April 2024
  • hepatitis C that was developed by Gilead Sciences. After completing Phase III clinical trials, on February 10, 2014, Gilead filed for U.S. approval of a...
    10 KB (694 words) - 23:39, 3 January 2024
  • by Gilead Sciences, and subsequently the Indian Patent Office in New Delhi approved the drug. After receiving exclusivity with the patent, Gilead Sciences...
    48 KB (4,940 words) - 09:15, 19 April 2024
  • has license agreements with Bristol-Myers Squibb for Atazanavir and Gilead Sciences for Tenofovir as part of their Global Access Programs. Roche has signed...
    10 KB (848 words) - 17:00, 22 April 2024
  • Thumbnail for Filgotinib
    The applicant for this medicinal product is Gilead Sciences Ireland UC. 19 August 2020: FDA rejects Gilead’s filing for approval of filgotinib over toxicity...
    24 KB (2,248 words) - 15:19, 11 April 2024
  • Thumbnail for Sacituzumab govitecan
    Sacituzumab govitecan, sold under the brand name Trodelvy by Gilead Sciences, is a Trop-2-directed antibody and topoisomerase inhibitor drug conjugate...
    30 KB (2,404 words) - 20:20, 27 April 2024
  • Laboratoires Garnierdivision of Nestlé GE Healthcare – GE Healthcare GileadGilead Sciences GlaxoSmithKline – GlaxoSmithKline Grünenthal – Grünenthal Ltd Grifols...
    8 KB (815 words) - 09:15, 2 April 2024
  • Thumbnail for Lenacapavir
    Lenacapavir (category Gilead Sciences)
    it to be a first-in-class medication. Lenacapavir was developed by Gilead Sciences. As of 2021, it is in phase II/III clinical trials. It is being investigated...
    20 KB (1,270 words) - 04:27, 31 March 2024